England’s NICE Wants Industry Involvement In HTA Sandbox Projects

Pharmaceutical companies are being encouraged to reach out to NICE in relation to its HTA Innovation Lab, which provides a sandbox environment in which the health technology assessment body can test new methods of evaluating “innovative and disruptive” therapies.

Philip Morgan, Andrew Champion, Jamie Elvidge and Jeanette Kusel at the NICE annual conference 2025 (Norstella)

More from Health Technology Assessment

More from Market Access